Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
The Saudi Food & Drug Authority (SFDA) released guidelines for Economic Evaluation Studies to assess…
Read moreThe collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and…
Read moreIncrease in net spending and challenges in balancing healthcare budgets highlighted in AIFA’s latest…
Read moreNew doctrine accelerates drug development for rare diseases and oncology by adjusting evidence requi…
Read moreGermany’s new Medicines Research Act allows confidential rebates for pharma companies, but recent am…
Read moreNew ground-breaking gene therapy for haemophilia B enters NHS England’s Innovative Medicines Fund, o…
Read moreThe rise of personalised medicine is revolutionizing healthcare, prompting a re-evaluation of tradit…
Read moreOur Corporate Social Responsibility (CSR) Team will focus on employee wellbeing, the local community…
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova…
Read more